CompletedNCT00015769
Levetiracetam for mood symptoms in bipolarity
About this title
Read the official source — NCT00015769Medication studyUnited States
Understand this study
Who was this study for?
This study was for people with bipolarity. Other eligibility criteria applied.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateApril 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Not clearly listed
- Official registry ID
- NCT00015769
- Official title
Show the full official title
Pilot Evaluation of Levetiracetam (Keppra® (Registered Trademark)) in Bipolar Illness
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including levetiracetam.
Who was this study for?
This study was for people with bipolarity. Other eligibility criteria applied.
